anaphylaxis%20(pediatric)
ANAPHYLAXIS (PEDIATRIC)

Anaphylaxis is a serious generalized or systemic hypersensitivity reaction that is rapid in onset and potentially fatal.

Diagnosis can be made if it is acute in onset of minute to several hour duration that involves the skin, mucosal tissue or both plus having signs & symptoms either respiratory or cardiovascular compromise.

It involves immunological response with IgE, IgG or immune complexes. Non-immunological mechanisms are also involved and termed as nonallergic anaphylaxis that is relatively uncommon in children.

Protracted, severe anaphylaxis are reactions occurring up to 32 hours despite aggressive management.

 

Supportive Therapy

  • Establish and maintain airway
    • Endotracheal tube, cricothyrotomy or needle cricothyrotomy may be performed if indicated

Oxygen

  • High flow O2 (6-8 L/min) via non-rebreathing mask or endotracheal tube in patients experiencing respiratory symptoms, hypoxemia, or hypotension related to anaphylaxis
  • Continuous pulse oximetry and arterial blood gas determination should guide oxygen therapy

Fluid Support

  • Maintain an IV access using wide bore needles or cannulas
  • Rapid administration of 1-2 liters of isotonic (0.9%) saline solution may be indicated
    • Children: 10 mL/kg for the first 5-10 minutes
  • For hypotensive patients or those with cardiovascular collapse, IV/intraosseous administration of normal saline at 20 mL/kg is recommended
  • Inotropic support with Dopamine or Epinephrine infusion should be started if >40 mL/kg is needed
    • Invasive BP monitoring may be required
  • If IV access is delayed or impossible, intraosseus route can be used

Additional intervention for cardiopulmonary arrest occurring during anaphylaxis

  • Cardiopulmonary resuscitation and advanced cardiac life support measures
  • High dose Epinephrine (IV)
  • Rapid volume expansion
  • Prolonged resuscitation efforts are encouraged
  • Transport to ICU, as setting dictates
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
29 Nov 2018
Pulmonary hypertension (PH) is associated with underlying risk factors in children with congenital hyperinsulinism (HI) treated with diazoxide, reports a study. Other adverse events, however, do not show any identifiable risk profile.
14 Mar 2017
Levels of serum proteins, particularly the leucine-rich alpha-2-glycoprotein 1 (LRG1), can be used as biomarkers for the diagnosis of Kawasaki disease (KD) and accurate identification of its phases, a new proteomic study reveals.
18 Jan 2019
Azithromycin treatment in children with recurrent asthma-like symptoms acutely disrupts gut microbiota composition, a recent study has found.
01 Sep 2016
Salmeterol/fluticasone exhibits comparable serious asthma-related event risk with that of fluticasone alone in children with asthma, a prospective study shows.